^
    Back
    Association details:
    Biomarker:YTHDC1 underexpression
    Cancer:Bladder Cancer
    Drug:cisplatin (DNA synthesis inhibitor)
    Direction:Resistant
    Evidence:
    Evidence Level:
    Resistant: C3 – Early Trials
    Source:
    Cell Prolif
    Title:

    YTHDC1 positively regulates PTEN expression and plays a critical role in cisplatin resistance of bladder cancer

    Published date:
    04/19/2023
    Excerpt:
    Low YTHDC1 expression indicated poor cisplatin sensitivity in bladder cancer patients.
    DOI:
    10.1111/cpr.13404